Keyphrases
Cancer Progression
100%
Gemcitabine
100%
Pancreas Cancer
100%
Sigma-2 Receptor Ligands
100%
Sigma-2 Ligand
60%
Pancreatic Cancer
40%
Tumor Volume
40%
Induced Apoptosis
40%
Apoptosis
20%
Cancer Cells
20%
Clinical Investigation
20%
Conventional Chemotherapy
20%
Targeted Treatment
20%
Binding Affinity
20%
In Vivo Model
20%
Combination Treatment
20%
Rank Order
20%
Sigma-2 Receptor
20%
Clinical Model
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Growth
100%
Pancreas Cancer
100%
Sigma 2 Opiate Receptor
100%
Gemcitabine
100%
Neoplasm
40%
Malignant Neoplasm
20%
Chemotherapy
20%
Biochemistry, Genetics and Molecular Biology
Gemcitabine
100%
Programmed Cell Death
60%
Tumor Volume
40%
Cancer Cell
20%
Binding Affinity
20%
Ordo
20%